Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized open-label study of Trizivir + tenofovir in multidrug-resistant HIV patients with virologic failure
2005-002203-17Phase 4Active
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of abacavir and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: Proportion of patients with more than 30% decline in CD4 lymphocyte count at week 48. Started Jul 2005; status: active.
02
Drugs
abacavirtenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-002203-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002203-17.